1 Introduction 11
1.1 Industry Definition and Research Scope 11
1.1.1 Industry Definition 11
1.1.2 Research Scope 12
1.2 Research Methodology 15
1.2.1 Overview of Market Research Methodology 15
1.2.2 Market Assumption 16
1.2.3 Secondary Data 16
1.2.4 Primary Data 16
1.2.5 Data Filtration and Model Design 17
1.2.6 Market Size/Share Estimation 18
1.2.7 Research Limitations 19
1.3 Executive Summary 20
2 Market Overview and Dynamics 23
2.1 Market Size and Forecast 23
2.1.1 Impact of COVID-19 on World Economy 24
2.1.2 Impact of COVID-19 on the Market 26
2.2 Major Growth Drivers 28
2.3 Market Restraints and Challenges 33
2.4 Emerging Opportunities and Market Trends 36
2.5 Porters Fiver Forces Analysis 40
3 Segmentation of Global Market by Product 45
3.1 Market Overview by Product 45
3.2 Assay Kits & Consumables 47
3.3 Analyzers & Instruments 48
4 Segmentation of Global Market by Test Type 49
4.1 Market Overview by Test Type 49
4.2 Autoantibodies and Immunologic Tests 51
4.2.1 Antinuclear Antibody Tests 53
4.2.2 Anti-cyclic Citrullinated Peptide 54
4.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) 55
4.2.4 Rheumatoid Factor 56
4.2.5 Thyroid Antibody Tests 57
4.2.6 Other Autoantibodies and Immunologic Tests 58
4.3 Inflammatory Marker Tests 59
4.3.1 C-Reactive Protein (CRP) 61
4.3.2 Erythrocyte Sedimentation Rate (ESR) 62
4.3.3 Other Inflammatory Marker Tests 63
4.4 Routine Laboratory Tests 64
4.4.1 Urinalysis 66
4.4.2 Complete Blood Count (CBC) Tests 67
4.4.3 Other Routine Laboratory Tests 68
4.5 Other Test Types 69
5 Segmentation of Global Market by Disease Type 70
5.1 Market Overview by Disease Type 70
5.2 Systemic Autoimmune Disease 72
5.2.1 Rheumatoid Arthritis 74
5.2.2 Systemic Lupus Erythematosus (SLE) 75
5.2.3 Psoriasis/Psoriatic Arthritis 76
5.2.4 Other Systemic Autoimmune Diseases 77
5.3 Localized Autoimmune Disease 78
5.3.1 Thyroiditis 80
5.3.2 Multiple Sclerosis 81
5.3.3 Inflammatory Bowel Disease 82
5.3.4 Type 1 Diabetes 83
5.3.5 Other Localized Autoimmune Diseases 84
6 Segmentation of Global Market by Gender 85
6.1 Market Overview by Gender 85
6.2 Female Patients 87
6.3 Male Patients 88
7 Segmentation of Global Market by Age 89
7.1 Market Overview by Age 89
7.2 < 44 91
7.3 44 - 64 92
7.4 > 64 93
8 Segmentation of Global Market by End User 94
8.1 Market Overview by End User 94
8.2 Hospitals 96
8.3 Clinics 97
8.4 Diagnostic Labs 98
8.5 Other End Users 99
9 Segmentation of Global Market by Region 100
9.1 Geographic Market Overview 2021-2031 100
9.2 North America Market 2021-2031 by Country 104
9.2.1 Overview of North America Market 104
9.2.2 U.S. 108
9.2.3 Canada 111
9.2.4 Mexico 113
9.3 European Market 2021-2031 by Country 115
9.3.1 Overview of European Market 115
9.3.2 Germany 119
9.3.3 U.K. 121
9.3.4 France 123
9.3.5 Spain 125
9.3.6 Italy 127
9.3.7 Russia 129
9.3.8 Rest of European Market 131
9.4 Asia-Pacific Market 2021-2031 by Country 133
9.4.1 Overview of Asia-Pacific Market 133
9.4.2 Japan 137
9.4.3 China 140
9.4.4 Australia 142
9.4.5 India 144
9.4.6 South Korea 146
9.4.7 Rest of APAC Region 148
9.5 South America Market 2021-2031 by Country 150
9.5.1 Argentina 153
9.5.2 Brazil 155
9.5.3 Chile 157
9.5.4 Rest of South America Market 159
9.6 MEA Market 2021-2031 by Country 160
9.6.1 UAE 163
9.6.2 Saudi Arabia 165
9.6.3 South Africa 167
9.6.4 Other National Markets 169
10 Competitive Landscape 170
10.1 Overview of Key Vendors 170
10.2 New Product Launch, Partnership, Investment, and M&A 173
10.3 Company Profiles 174
Abbott Laboratories 174
Beckman Coulter, Inc. 176
Biomerieux SA 177
Bio-rad Laboratories Inc. 178
F. Hoffmann-la Roche Ltd. 179
Hemagen Diagnostics Inc. 180
Myriad Genetics Inc. 181
PerkinElmer Inc. (Euroimmun AG) 182
Quest Diagnostics Inc. 183
Siemens Healthineers Inc. 184
Thermo Fisher Scientific Inc. 185
Trinity Biotech PLC 186
Werfen Company (Inova Diagnostics Inc.) 187
RELATED REPORTS 188